{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:44:27Z","timestamp":1790171067605,"version":"4.1.0"},"reference-count":102,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Primary liver cancer is predicted to be the sixth most common cancer and the fourth leading cause of cancer mortality worldwide. Recent studies identified nonalcoholic fatty liver disease (NAFLD) as the underlying cause in 13\u201338.2% of patients with hepatocellular carcinoma unrelated to viral hepatitis and alcohol abuse. NAFLD progresses to nonalcoholic steatohepatitis (NASH), which increases the risk for the development of liver fibrosis, cirrhosis, and hepatocellular carcinoma. NAFLD is characterized by dysregulation of lipid metabolism. In addition, lipid metabolism is effected not only in NAFLD, but also in a broad range of chronic liver diseases and tumor development. Cancer cells manipulate a variety of metabolic pathways, including lipid metabolism, in order to build up their own cellular components. Identifying tumor dependencies on lipid metabolism would provide options for novel targeting strategies. This review article summarizes the research evidence on metabolic reprogramming and focuses on lipid metabolism in NAFLD, NASH, fibrosis, and cancer. As alternative routes of acetyl-CoA production for fatty acid synthesis, topics on glutamine and acetate metabolism are included. Further, studies on small compound inhibitors targeting lipid metabolism are discussed. Understanding reprogramming strategies in liver diseases, as well as the visualization of the metabolism reprogramming networks, could uncover novel therapeutic options.<\/jats:p>","DOI":"10.3390\/ijms21186799","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T10:30:12Z","timestamp":1600252212000},"page":"6799","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine\/Acetate Signaling"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-7512","authenticated-orcid":false,"given":"Yoshiaki","family":"Sunami","sequence":"first","affiliation":[{"name":"Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, University Medical Center Halle, 06120 Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmark of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sunami, Y., Rebelo, A., and Kleeff, J. (2017). Lipid metabolism and lipid droplets in pancreatic cancer and stellate cells. Cancers, 10.","DOI":"10.3390\/cancers10010003"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.011338","article-title":"Hooked on fat: The role of lipid synthesis in cancer metabolism and tumour development","volume":"6","author":"Baenke","year":"2013","journal-title":"Dis. Models Mech."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/1873-3468.13097","article-title":"Activity and structure of human acetyl-CoA carboxylase targeted by a specific inhibitor","volume":"592","author":"Jang","year":"2018","journal-title":"FEBS Lett."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/nm.3372","article-title":"Single Phosphorylation Sites in Acc1 and Acc2 Regulate Lipid Homeostasis and the Insulin-Sensitizing Effects of Metformin","volume":"19","author":"Fullerton","year":"2013","journal-title":"Nat. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20484","DOI":"10.1038\/srep20484","article-title":"Co-activation of AKT and c-Met Triggers Rapid Hepatocellular Carcinoma Development via the mTORC1\/FASN Pathway in Mice","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","article-title":"Cholesterol Biosynthesis Supports the Growth of Hepatocarcinoma Lesions Depleted of Fatty Acid Synthase in Mice and Humans","volume":"69","author":"Che","year":"2020","journal-title":"Gut"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/14656566.2019.1583209","article-title":"ETC-1002 (Bempedoic Acid) for the Management of Hyperlipidemia: From Preclinical Studies to Phase 3 Trials","volume":"20","author":"Ruscica","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101006","DOI":"10.1016\/j.plipres.2019.101006","article-title":"ATP-citrate Lyase (ACLY) in Lipid Metabolism and Atherosclerosis: An Updated Review","volume":"77","author":"Feng","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate Lyase Inhibition by Bempedoic Acid Decreases LDL-C and Attenuates Atherosclerosis","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gu, L., Zhu, Y., Lin, X., Lu, B., Zhou, X., Zhou, F., Zhao, Q., and Li, Y. (2020). The IKK\u03b2-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis. Hepatology, Online ahead of print.","DOI":"10.1002\/hep.31249"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","article-title":"Acetyl-CoA Carboxylase Inhibition by ND-630 Reduces Hepatic Steatosis, Improves Insulin Sensitivity, and Modulates Dyslipidemia in Rats","volume":"113","author":"Harriman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.cgh.2018.04.042","article-title":"Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis","volume":"16","author":"Lawitz","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1053\/j.gastro.2018.07.027","article-title":"GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease","volume":"155","author":"Loomba","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2018.08.020","article-title":"Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma","volume":"29","author":"Lally","year":"2019","journal-title":"Cell Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-15-0126","article-title":"Molecular Pathways: Fatty Acid Synthase","volume":"21","author":"Jones","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1073\/pnas.1808834116","article-title":"Inhibition of De Novo Lipogenesis Targets Androgen Receptor Signaling in Castration-Resistant Prostate Cancer","volume":"116","author":"Zadra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nchembio.1603","article-title":"A Human Fatty Acid Synthase Inhibitor Binds \u03b2-ketoacyl Reductase in the Keto-Substrate Site","volume":"10","author":"Hardwicke","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"24787","DOI":"10.18632\/oncotarget.25361","article-title":"Preclinical Evaluation of Novel Fatty Acid Synthase Inhibitors in Primary Colorectal Cancer Cells and a Patient-Derived Xenograft Model of Colorectal Cancer","volume":"9","author":"Zaytseva","year":"2018","journal-title":"Oncotarget"},{"key":"ref_25","first-page":"103","article-title":"Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic De Novo Lipogenesis in Males With Metabolic Abnormalities","volume":"72","author":"Parks","year":"2019","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1021\/jm501543u","article-title":"Repositioning Proton Pump Inhibitors as Anticancer Drugs by Targeting the Thioesterase Domain of Human Fatty Acid Synthase","volume":"58","author":"Fako","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jphp.12870","article-title":"Lansoprazole Prevents the Progression of Liver Fibrosis in Non-Alcoholic Steatohepatitis Model Rats","volume":"70","author":"Nishi","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2016.09.007","article-title":"Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients with Cirrhosis in a Population Study","volume":"152","author":"Tsai","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bcp.13615","article-title":"Safe Use of Proton Pump Inhibitors in Patients with Cirrhosis","volume":"84","author":"Weersink","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1111\/febs.13681","article-title":"Lipid desaturation\u2014The next step in targeting lipogenesis in cancer?","volume":"283","author":"Peck","year":"2016","journal-title":"FEBS J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver","volume":"58","author":"Kotronen","year":"2009","journal-title":"Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13018","DOI":"10.1073\/pnas.95.22.13018","article-title":"Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis","volume":"95","author":"Cases","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121689","article-title":"Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia","volume":"451","author":"Zammit","year":"2013","journal-title":"Biochem. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.30765","article-title":"Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis without Increasing Inflammation or Fibrosis in Mice","volume":"70","author":"Gluchowski","year":"2019","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eaav9701","DOI":"10.1126\/scitranslmed.aav9701","article-title":"Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis","volume":"11","author":"Amin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1053\/j.gastro.2017.01.021","article-title":"Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6","volume":"152","author":"Lai","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1080\/01635581.2012.716138","article-title":"Plasma fatty acid composition in patients with pancreatic cancer: Correlations to clinical parameters","volume":"64","author":"Vecka","year":"2012","journal-title":"Nutr. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-012-2354-4","article-title":"High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients","volume":"137","author":"Holder","year":"2013","journal-title":"Breast Cancer Res. Treat"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"39970","DOI":"10.18632\/oncotarget.9461","article-title":"SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2017.06.015","article-title":"Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation","volume":"67","author":"Ma","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-018-0711-9","article-title":"Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN","volume":"37","author":"Ran","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41419-018-0681-z","article-title":"CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma","volume":"9","author":"Lu","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.stem.2016.11.004","article-title":"Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells","volume":"20","author":"Li","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0030-1247130","article-title":"Stem cells in hepatocarcinogenesis: Evidence from genomic data","volume":"30","author":"Marquardt","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cmet.2007.10.014","article-title":"Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis","volume":"6","author":"Miyazaki","year":"2007","journal-title":"Cell Metab."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Li, L., Wang, C., Calvisi, D.F., Evert, M., Pilo, M.G., Jiang, L., Yuneva, M., and Chen, X. (2013). SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075104"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1053\/j.gastro.2018.07.032","article-title":"Deletion of Stearoyl-CoA Desaturase-1 From the Intestinal Epithelium Promotes Inflammation and Tumorigenesis, Reversed by Dietary Oleate","volume":"155","author":"Ducheix","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"12501","DOI":"10.1073\/pnas.0503132102","article-title":"Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development","volume":"102","author":"Miyazaki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","article-title":"Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity","volume":"566","author":"Vriens","year":"2019","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1248\/bpb.b12-00702","article-title":"A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis","volume":"36","author":"Kurikawa","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hep4.1107","article-title":"Role of Aramchol in steatohepatitis and fibrosis in mice","volume":"1","author":"Delgado","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1021\/jm200319u","article-title":"Development of a Liver-Targeted stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia","volume":"54","author":"Oballa","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional Control of Hepatic Lipid Metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2015.04.010","article-title":"Targeting SREBPs for treatment of the metabolic syndrome","volume":"36","author":"Soyal","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/onc.2015.179","article-title":"Oncogenic PI3K and K-Ras Stimulate De Novo Lipid Synthesis Through mTORC1 and SREBP","volume":"35","author":"Ricoult","year":"2016","journal-title":"Oncogene"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.3390\/ijms15057124","article-title":"SREBP-1 Has a Prognostic Role and Contributes to Invasion and Metastasis in Human Hepatocellular Carcinoma","volume":"15","author":"Li","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41419-019-1884-7","article-title":"SREBP-1 Inhibitor Betulin Enhances the Antitumor Effect of Sorafenib on Hepatocellular Carcinoma via Restricting Cellular Glycolytic Activity","volume":"10","author":"Yin","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2010.12.004","article-title":"Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques","volume":"13","author":"Tang","year":"2011","journal-title":"Cell Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/hep.29018","article-title":"Inhibition of the Sterol Regulatory Element-Binding Protein Pathway Suppresses Hepatocellular Carcinoma by Repressing Inflammation in Mice","volume":"65","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11101-019-09623-1","article-title":"Betulin and betulinic acid: Triterpenoids derivatives with a powerful biological potential","volume":"18","author":"Hordyjewska","year":"2019","journal-title":"Phytochem. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrm2336","article-title":"Cellular cholesterol trafficking and compartmentalization","volume":"9","author":"Ikonen","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: Mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cb.01.110185.000245","article-title":"Receptor-mediated endocytosis: Concepts emerging from the LDL receptor system","volume":"1","author":"Goldstein","year":"1985","journal-title":"Annu. Rev. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41419-019-2054-7","article-title":"ASPP2 Inhibits Tumor Growth by Repressing the Mevalonate Pathway in Hepatocellular Carcinoma","volume":"10","author":"Liang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural Mechanism for Statin Inhibition of HMG-CoA Reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.28506","article-title":"Atorvastatin and Fluvastatin Are Associated With Dose-Dependent Reductions in Cirrhosis and Hepatocellular Carcinoma, Among Patients With Hepatitis C Virus: Results From ERCHIVES","volume":"64","author":"Simon","year":"2016","journal-title":"Hepatology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1038\/s41467-018-07590-3","article-title":"Discovery of a Potent HMG-CoA Reductase Degrader That Eliminates Statin-Induced Reductase Accumulation and Lowers Cholesterol","volume":"9","author":"Jiang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1194\/jlr.M067488","article-title":"Statins Increase Hepatic Cholesterol Synthesis and Stimulate Fecal Cholesterol Elimination in Mice","volume":"57","author":"Schonewille","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1126\/science.122.3168.501","article-title":"Nutrition Needs of Mammalian Cells in Tissue Culture","volume":"122","author":"Eagle","year":"1955","journal-title":"Science"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/0016-5085(94)90024-8","article-title":"Overexpression of Glutamine Synthetase in Human Primary Liver Cancer","volume":"106","author":"Christa","year":"1994","journal-title":"Gastroenterology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ebiom.2018.11.063","article-title":"Targeting Glutaminase 1 Attenuates Stemness Properties in Hepatocellular Carcinoma by Increasing Reactive Oxygen Species and Suppressing Wnt\/beta-catenin Pathway","volume":"39","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4155\/fmc-2016-0190","article-title":"A Tale of Two Glutaminases: Homologous Enzymes with Distinct Roles in Tumorigenesis","volume":"9","author":"Katt","year":"2017","journal-title":"Future Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10602","article-title":"Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia","volume":"481","author":"Metallo","year":"2011","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","article-title":"Reductive carboxylation supports growth in tumour cells with defective mitochondria","volume":"481","author":"Mullen","year":"2011","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/cr.2012.5","article-title":"Breathless cancer cells get fat on glutamine","volume":"22","author":"Anastasiou","year":"2012","journal-title":"Cell Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/1541-7786.MCR-17-0061","article-title":"PPAR\u03b4 Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC","volume":"15","author":"Kim","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2019.05.012","article-title":"Therapeutic Targeting of Glutaminolysis as an Essential Strategy to Combat Cancer","volume":"98","author":"Mazurek","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1172\/JCI75836","article-title":"Targeted Inhibition of Tumor-Specific Glutaminase Diminishes Cell-Autonomous Tumorigenesis","volume":"125","author":"Xiang","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"15965","DOI":"10.1038\/ncomms15965","article-title":"Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism","volume":"8","author":"Biancur","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","article-title":"Glutamate Dehydrogenase 1 Signals Through Antioxidant Glutathione Peroxidase 1 to Regulate Redox Homeostasis and Tumor Growth","volume":"27","author":"Jin","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.celrep.2015.10.045","article-title":"Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization","volume":"13","author":"Mukhopadhyay","year":"2015","journal-title":"Cell Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41418-020-0491-6","article-title":"Inhibition of the Mitochondrial Citrate Carrier, Slc25a1, Reverts Steatosis, Glucose Intolerance, and Inflammation in Preclinical Models of NAFLD\/NASH","volume":"27","author":"Tan","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrm3841","article-title":"The growing landscape of lysine acetylation links metabolism and cell signaling","volume":"15","author":"Choudhary","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","article-title":"Acetyl coenzyme A: A central metabolite and second messenger","volume":"21","author":"Pietrocola","year":"2015","journal-title":"Cell Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1194\/jlr.M700378-JLR200","article-title":"Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome","volume":"48","author":"Watkins","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","article-title":"Acetate dependence of tumors","volume":"159","author":"Comerford","year":"2014","journal-title":"Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"E9499","DOI":"10.1073\/pnas.1806635115","article-title":"ACSS2 Promotes Systemic Fat Storage and Utilization Through Selective Regulation of Genes Involved in Lipid Metabolism","volume":"115","author":"Huang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","article-title":"Dietary Fructose Feeds Hepatic Lipogenesis via Microbiota-Derived Acetate","volume":"579","author":"Zhao","year":"2020","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrc.2016.87","article-title":"The metabolic fate of acetate in cancer","volume":"16","author":"Schug","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1007\/s11064-012-0857-3","article-title":"Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT)","volume":"37","author":"Moschen","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/096504017X14902648894463","article-title":"Regulation of Acetate Utilization by Monocarboxylate Transporter 1 (MCT1) in Hepatocellular Carcinoma (HCC)","volume":"26","author":"Jeon","year":"2018","journal-title":"Oncol. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.4562","article-title":"Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival","volume":"237","author":"Baenke","year":"2015","journal-title":"J. Pathol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1002\/cam4.1521","article-title":"Aberrant MCT4 and GLUT1 Expression Is Correlated with Early Recurrence and Poor Prognosis of Hepatocellular Carcinoma After Hepatectomy","volume":"7","author":"Chen","year":"2018","journal-title":"Cancer Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00432-014-1888-8","article-title":"Monocarboxylate Transporter 4 Predicts Poor Prognosis in Hepatocellular Carcinoma and Is Associated With Cell Proliferation and Migration","volume":"141","author":"Gao","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40170-016-0154-8","article-title":"Novel drugs that target the metabolic reprogramming in renal cell cancer","volume":"4","author":"Panka","year":"2016","journal-title":"Cancer Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e1601756","DOI":"10.1126\/sciadv.1601756","article-title":"Syrosingopine Sensitizes Cancer Cells to Killing by Metformin","volume":"2","author":"Benjamin","year":"2016","journal-title":"Sci. Adv."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal With Metformin Due to NAD+ Depletion in Cancer Cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6799\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:10:35Z","timestamp":1760177435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":102,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["ijms21186799"],"URL":"https:\/\/doi.org\/10.3390\/ijms21186799","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]}}}